ISIS PHARMACEUTICALS INC DEL's ticker is and the CUSIP is 464337AJ3. A total of 45 filers reported holding ISIS PHARMACEUTICALS INC DEL in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $18,309,000 | +50.1% | 18,208,000 | +50.3% | 0.26% | +56.1% |
| Q2 2021 | $12,199,000 | +1103.1% | 12,116,000 | +1111.6% | 0.16% | +465.5% |
| Q1 2020 | $1,014,000 | -41.0% | 1,000,000 | -33.3% | 0.03% | -9.4% |
| Q4 2019 | $1,719,000 | +8.6% | 1,500,000 | +8.2% | 0.03% | +3.2% |
| Q3 2019 | $1,583,000 | -44.0% | 1,386,000 | -41.9% | 0.03% | -41.5% |
| Q2 2019 | $2,828,000 | -72.7% | 2,386,000 | -68.8% | 0.05% | -73.1% |
| Q1 2019 | $10,347,000 | -83.4% | 7,640,000 | -86.9% | 0.20% | -65.4% |
| Q4 2018 | $62,466,000 | +1354.7% | 58,100,000 | +1240.3% | 0.57% | +736.8% |
| Q1 2018 | $4,294,000 | -86.6% | 4,335,000 | -85.7% | 0.07% | -86.5% |
| Q4 2017 | $32,129,000 | +11.2% | 30,365,000 | +11.7% | 0.50% | +16.9% |
| Q3 2017 | $28,888,000 | +17.9% | 27,195,000 | +19.0% | 0.43% | +7.5% |
| Q2 2017 | $24,499,000 | +89.7% | 22,860,000 | +71.2% | 0.40% | +113.3% |
| Q1 2017 | $12,915,000 | -15.9% | 13,350,000 | -11.0% | 0.19% | -17.5% |
| Q4 2016 | $15,348,000 | -39.5% | 15,000,000 | -44.6% | 0.23% | -30.7% |
| Q3 2016 | $25,384,000 | – | 27,100,000 | – | 0.33% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|